BONESUPPORT™‘s CERAMENT®|G Highly Effective Adjunct in the Single Stage Surgical Management of Chronic Osteomyelitis

23rd September 2020

BONESUPPORT™ Raises $37 Million (SEK 327 million) to Drive Product Sales and Deliver Further Value From CERAMENT® Injectable Drug Eluting Bioceramic Platform

23rd September 2020

BONESUPPORT™ Announces Key Corporate Appointment To Drive Growth in North America

23rd September 2020

Richard Davies Wins “Best CEO in the Biomaterials Industry” Award from European CEO Magazine

23rd September 2020

BONESUPPORT confirms election of Dr. Håkan Björklund as Chairman of the Board

23rd September 2020

Björn Westberg to join BONESUPPORT™ as Chief Financial Officer

23rd September 2020

BONESUPPORT™ – First Patient Recruited in Study Evaluating CERAMENT® G and CERAMENT® V in Patients Undergoing Hip and Knee Arthroplasty Revisions

23rd September 2020

BONESUPPORT™ APPOINTS HELENA L BRANDT AS HEAD OF HUMAN RESOURCES

22nd September 2020

BONESUPPORT HOLDING AB (publ) – Q3 2017 Interim Report – invitation to conference call and webcast

22nd September 2020

BONESUPPORT HOLDING AB (publ) – Interim Report – January – September 2017

22nd September 2020